Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Liou JP
------>authors3_c=
------>paper_class1=1
------>Impact_Factor=5.076
------>paper_class3=2
------>paper_class2=1
------>vol=47
------>confirm_bywho=None
------>insert_bywho=jpl
------>Jurnal_Rank=8.3
------>authors4_c=
------>comm_author=
------>patent_EDate=None
------>authors5_c=
------>publish_day=1
------>paper_class2Letter=None
------>page2=4257
------>medlineContent=
------>unit=000
------>insert_date=20050404
------>iam=1
------>update_date=None
------>author=???
------>change_event=2
------>ISSN=
------>authors_c=
------>score=420
------>journal_name=J. Med. Chem.
------>paper_name=Concise Synthesis of 1-Aroylindoles and 3-Aroylindoles, Combretastatin A-4 Analogues, as a Novel Class of Potent Antitubulin Agents.
------>confirm_date=None
------>tch_id=093131
------>pmid=15293996
------>page1=4247
------>fullAbstract=The synthesis and study of the structure-activity relationships of two new classes of synthetic antitubulin compounds based on 1-aroylindole and 3-aroylindole skeletons are described. Lead compounds 3, 10, and 14 displayed potent cytotoxicities with IC50 = 0.9-26 nM against human NUGC3 stomach, MKN45 stomach, MESSA uterine, A549 lung, and MCF-7 breast carcinoma cell lines. The inhibition of proliferation correlated with in vitro polymerization inhibitory activities. Structure-activity relationships revealed that 6-methoxy substitution of 3-aroylindoles and 5-methoxy substitution of 1-aroylindoles contribute to a significant extent for maximal activity by mimicking the para substitution of the methoxy group to the carbonyl group in the case of aminobenzophenones. Addition of a methyl group at the C-2 position on the indole ring exerts an increased potency. The 3,4,5-trimethoxybenzoyl moiety was necessary for better activity but not essential and can be replaced by 3,5-dimethoxybenzoyl and 3,4,5-trimethoxybenzyl moieties. We conclude that 1- and 3-aroylindoles constitute an interesting new class of antitubulin agents with the potential to be clinically developed for cancer treatment.
------>tmu_sno=None
------>sno=10650
------>authors2=Chang YL
------>authors3=Guo FM
------>authors4=Chang CW
------>authors5=Chang JY
------>authors6=Lee SJ,.Hsieh HP
------>authors6_c=
------>authors=Liou JP
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=
------>publish_area=0
------>updateTitle=Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=
------>patent_SDate=None
------>update_bywho=None
------>publish_year=2004
------>submit_flag=None
------>publish_month=1
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z